脑卒中患者药物素养现状及影响因素分析

doi:10.12183/j.scjpm.2023.1526

摘要/Abstract

摘要： 目的对脑卒中患者药物素养水平展开调查并分析其影响因素。方法以2022年2月至2023年2月江苏省人民医院接受诊治的400例脑卒中患者为研究对象。采用一般资料调查问卷、中文版药物素养评估量表（MedLitRxSE）、医疗社会支持量表（MOS-SSS）开展调查,通过描述性分析法、单因素分析法及多重线性回归分析法对脑卒中患者药物素养现状及其影响因素进行统计学分析。结果脑卒中患者MedLitRxSE评分为（8.78±3.51）分;MOS-SSS评分为（69.72±14.96）分。年龄（β'=-0.294）、文化程度（β'=0.196）、家庭人均月收入（β'=0.723）、家族脑卒中病史（β'=0.457）及医疗社会支持（β'=0.535）是脑卒中患者药物素养水平的主要影响因素。结论脑卒中患者药物素养普遍处于中等水平,临床医护人员在日常工作中需重点关注高龄患者药物素养水平及合理用药情况,并根据主要影响因素制定针对性的护理干预方案,以提高脑卒中患者药物素养水平及用药安全。

关键词: 脑卒中, 药物素养, 医疗社会支持, 用药安全, 影响因素

中图分类号:

韩艳, 李彬彬, 唐金荣. 脑卒中患者药物素养现状及影响因素分析[J]. 华南预防医学, 2023, 49(12): 1526-1529.

参考文献

[1] Feigin VL, Stark BA, Johnson CO, et al.Global, regional, and national burden of stroke and its risk factors,1990-2019: A systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Neurol,2021,20(10):795-820.
[2] Ma Q, Li R, Wang L, et al.Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: An analysis for the Global Burden of Disease Study 2019[J].Lancet Public Health,2021,6(12):e897-e906.
[3] Donneyong MM, Fischer MA, Langston MA, et al.Examining the drivers of racial/ethnic disparities in non-adherence to antihypertensive medications and mortality due to heart disease and stroke: A county-level analysis[J].Int J Environ Res Public Health,2021,18(23):12702.
[4] Chang X, Wang K, Wang Y, et al.Medication literacy in Chinese patients with stroke and associated factors: A cross-sectional study[J].Int J Environ Res Public Health,2022,20(1):620.
[5] 刘梦如,梁发存,尹艳茹,等.脑卒中患者健康素养的潜在剖面分析及与健康行为差异比较[J].军事护理,2023,40(4):52-55,70.
[6] Tian X, Yu M, Sun Y, et al.Evidence-based summary for the safety of multiple medication in elderly patients with ischemic stroke[J].Ann Transl Med,2022,10(4):202.
[7] Sui W, Wan LH.Association between patient activation and medication adherence in patients with stroke: A cross-sectional study[J].Front Neurol,2021,12:722711.
[8] American Medical Association.Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs. Health literacy: Report of the council on scientific affairs[J].JAMA,1999,281(6):552-557.
[9] 刘玉杰,杨方英.老年共病病人药物素养研究进展[J].护理研究,2023,37(9):1627-1630.
[10] Foubert K, Mehuys E, Claes L, et al.A shared medication scheme for community dwelling older patients with polypharmacy receiving home health care: Role of the community pharmacist[J].Acta Clin Belgi,2019,74(5):326-333.
[11] 曾进胜,蒲传强.我国各类主要脑血管病诊断要点演变与更新[J].中华神经科杂志,2019:52(9):681-683.
[12] Sauceda JA, Loya AM, Sias JJ, et al.Medication literacy in Spanish and English: Psychometric evaluation of a new assessment tool[J]. J Am Pharm Assoc,2012,52(6):e231-e240.
[13] 郑凤,钟竹青,丁四清,等.药物素养评估量表的编译与评价[J].中南大学学报(医学版),2016,41(11):1226-1231.
[14] 郑凤,丁四清,沈志莹,等.门诊患者的药物素养现状调查[J].护理学杂志,2017,32(11):26-29.
[15] Sherbourne CD, Stewart AL.The MOS social support survey[J].Soc Sci Med,1991,32(6):705-714.
[16] Yu DS, Lee DT, Woo J.Psychometric testing of the Chinese version of the medical outcomes study social support survey (MOS-SSS-C)[J].Res Nurs Health,2004,27(2):135-143.
[17] 陈翠萍,马桂芬,杨春琴,等.医疗社会支持量表中文版应用于脑卒中病人的信效度测量[J].护理研究,2015,29(32):3994-3996.
[18] 国家卫生健康委办公厅.中国脑卒中防治指导规范(2021年版)[EB/OL]. (2021-08-31)[2022-12-15].http://www.nhc.gov.cn/yzygj/s3593/202108/50c4071a86df4bfd9666e9ac2aaac605. httml.
[19] 闫志新,苏慧敏,靳志利,等.缺血性脑卒中患者二级预防现状及影响因素研究[J].华南预防医学,2023,49(2):170-173.
[20] Pan Y, Li Z, Li J, et al.Residual risk and its risk factors for ischemic stroke with adherence to guideline-based secondary stroke prevention[J].J Stroke,2021,23(1):51-60.
[21] Zhao Y, Hua X, Ren X, et al.Increasing burden of stroke in China: A systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality[J]. Int J Stroke,2023,18(3):259-267.
[22] Elisabeth Stømer U, Klopstad Wahl A, Gunnar Gøransson L, et al.Health literacy in kidney disease: Associations with quality of life and adherence[J]. J Ren Care,2020,46(2):85-94.
[23] Tromp J, Bamadhaj S, Cleland JGF, et al.Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): A cohort study[J].Lancet Glob Health,2020,8(3):e411-e422.